Correction to the Trends From the Field article, “Risk Stratification for Return Emergency Department Visits Among High-Risk Patients,” published in the August 2017 issue of The American Journal of Managed Care®.
Am J Manag Care. 2019;25(3):140In the Trends From the Field article, “Risk Stratification for Return Emergency Department Visits Among High-Risk Patients,” published in the August 2017 issue of The American Journal of Managed Care®, an author’s initials were incorrect in the Author Affiliations and Authorship Information sections. The initials for Wei Duan-Porter, MD, PhD, should have been “WD-P.”
Additionally, the initials of another author were inadvertently omitted from the Author Affiliations section. The affiliation of Chad Kessler, MD, should have read “Ambulatory Care Service, Durham VA Medical Center (CK), Durham, NC.”
Telephone Follow-Up on Medicare Patient Surveys Remains Critical
January 16th 2025Including a telephone component in Medicare Consumer Assessment of Healthcare Providers and Systems survey administration continues to be valuable because telephone responses comprise a substantial portion of responses for several underserved groups.
Read More
Quantifying the Altruism Value for a Rare Pediatric Disease: Duchenne Muscular Dystrophy
January 14th 2025Altruism values for treatments of rare, severe pediatric diseases have not been estimated. This study found the altruism value for a hypothetical new Duchenne muscular dystrophy treatment to be $80 per year.
Read More
Telephone Follow-Up on Medicare Patient Surveys Remains Critical
January 16th 2025Including a telephone component in Medicare Consumer Assessment of Healthcare Providers and Systems survey administration continues to be valuable because telephone responses comprise a substantial portion of responses for several underserved groups.
Read More
Quantifying the Altruism Value for a Rare Pediatric Disease: Duchenne Muscular Dystrophy
January 14th 2025Altruism values for treatments of rare, severe pediatric diseases have not been estimated. This study found the altruism value for a hypothetical new Duchenne muscular dystrophy treatment to be $80 per year.
Read More
2 Commerce Drive
Cranbury, NJ 08512